Published by Benjamin Chiou on 20th March 2026
(Sharecast News) - Swiss pharma giant Novartis is to pay up to $3bn to Synnovation Therapeutics to acquire a promising breast-cancer treatment that has shown to reduce the unwanted side effects of available medicines.
URL: http://www.digitallook.com/dl/news/story/35801416/...